C. Leigh Allen

Dr. C. Leigh Allen

orcid

Research Focus & Metrics

Academic Career Length

70Years (1957-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2016 in Nature
Verified
Journal Article
Open access
PDF file
EDEric J. Drake
Eric J. Drake
BMBradley R. Miller
Bradley R. Miller
CSCe Shi
Ce Shi
JTJeffrey T. Tarrasch
Jeffrey T. Tarrasch
JSJesse A. Sundlov
Jesse A. Sundlov
AGAndrew M. Gulick
Andrew M. Gulick
X-ray crystal structures of two distinct steps in the catalytic cycle of non-ribosomal peptide synthetases are described, offering the potential to generate novel products through engineering enzyme activity. Non-ribosomal peptides, such as the antibiotic vancomycin and the immunosuppressant cyclosporin A, are peptidic secondary metabolites produced by microorganisms. Non-ribosomal peptide synthetases (NRPSs) are a family of large enzymes that utilize multiple catalytic domains to catalyse sequential steps in the biosynthetic pathway of this family of 'natural products'. Two papers in this issue of Nature present X-ray crystal structures that indicate that NRPSs are substantially more dynamic than previously believed. Andrew Gulick and colleagues studied two holo-non-ribosomal peptide synthetase modules, each revealing a distinct step in the catalytic cycle. Martin Schmeing and colleagues report several structures of LgrA, which is involved in the biosynthesis of the antibiotic gramicidin. Many important natural products are produced by multidomain non-ribosomal peptide synthetases (NRPSs)1,2,3,4. During synthesis, intermediates are covalently bound to integrated carrier domains and transported to neighbouring catalytic domains in an assembly line fashion5. Understanding the structural basis for catalysis with non-ribosomal peptide synthetases will facilitate bioengineering to create novel products. Here we describe the structures of two different holo-non-ribosomal peptide synthetase modules, each revealing a distinct step in the catalytic cycle. One structure depicts the carrier domain cofactor bound to the peptide bond-forming condensation domain, whereas a second structure captures the installation of the amino acid onto the cofactor within the adenylation domain. These structures demonstrate that a conformational change within the adenylation domain guides transfer of intermediates between domains. Furthermore, one structure shows that the condensation and adenylation domains simultaneously adopt their catalytic conformations, increasing the overall efficiency in a revised structural cycle. These structures and the single-particle electron microscopy analysis demonstrate a highly dynamic domain architecture and provide the foundation for understanding the structural mechanisms that could enable engineering of novel non-ribosomal peptide synthetases.

29 July 2017 in Molecular Microbiology
Verified
Journal Article
Open access
PDF file
MMMorgan E. Milton
Morgan E. Milton
CAC. Leigh Allen
C. Leigh Allen
EFErik A. Feldmann
Erik A. Feldmann
BBBenjamin Bobay
Benjamin Bobay
DJDavid K. Jung
David K. Jung
JCJohn Cavanagh
John Cavanagh
Summary: With antibiotic resistance increasing at alarming rates, targets for new antimicrobial therapies must be identified. A particularly promising target is the bacterial two‐component system. Two‐component systems allow bacteria to detect, evaluate and protect themselves against changes in the environment, such as exposure to antibiotics and also to trigger production of virulence factors. Drugs that target the response regulator portion of two‐component systems represent a potent new approach so far unexploited. Here, we focus efforts on the highly virulent bacterium Francisella tularensis tularensis. Francisella contains only three response regulators, making it an ideal system to study. In this study, we initially present the structure of the N‐terminal domain of QseB, the response regulator responsible for biofilm formation. Subsequently, using binding assays, computational docking and cellular studies, we show that QseB interacts with2‐aminoimidazole based compounds that impede its function. This information will assist in tailoring compounds to act as adjuvants that will enhance the effect of antibiotics.

1 December 2005 in Tetrahedron Letters
Verified
Journal Article
Closed access
DPDennis A. Parrish
Dennis A. Parrish
ZZZhou Zou
Zhou Zou
CAC. Leigh Allen
C. Leigh Allen
CDCynthia S. Day
Cynthia S. Day
SKS. Bruce King
S. Bruce King

10 February 2015 in Journal of the American Chemical Society
Verified
Journal Article
Open access
SKSvetlana A. Kholodar
Svetlana A. Kholodar
CAC. Leigh Allen
C. Leigh Allen
AGAndrew M. Gulick
Andrew M. Gulick
AMAndrew Murkin
Andrew Murkin
Several mechanistically unrelated enzymes utilize the binding energy of their substrate’s nonreacting phosphoryl group to accelerate catalysis. Evidence for the involvement of the phosphodianion in transition state formation has come from reactions of the substrate in pieces, in which reaction of a truncated substrate lacking its phosphorylmethyl group is activated by inorganic phosphite. What has remained unknown until now is how the phosphodianion group influences the reaction energetics at different points along the reaction coordinate. 1-Deoxy-d-xylulose-5-phosphate (DXP) reductoisomerase (DXR), which catalyzes the isomerization of DXP to 2-C-methyl-d-erythrose 4-phosphate (MEsP) and subsequent NADPH-dependent reduction, presents a unique opportunity to address this concern. Previously, we have reported the effect of covalently linked phosphate on the energetics of DXP turnover. Through the use of chemically synthesized MEsP and its phosphate-truncated analogue, 2-C-methyl-d-glyceraldehyde, the current study revealed a loss of 6.1 kcal/mol of kinetic barrier stabilization upon truncation, of which 4.4 kcal/mol was regained in the presence of phosphite dianion. The activating effect of phosphite was accompanied by apparent tightening of its interactions within the active site at the intermediate stage of the reaction, suggesting a role of the phosphodianion in disfavoring intermediate release and in modulation of the on-enzyme isomerization equilibrium. The results of kinetic isotope effect and structural studies indicate rate limitation by physical steps when the covalent linkage is severed. These striking differences in the energetics of the natural reaction and the reactions in pieces provide a deeper insight into the contribution of enzyme–phosphodianion interactions to the reaction coordinate.

30 May 2014 in Acta Crystallographica Section D Structural Biology
Verified
Journal Article
Open access
PDF file
CAC. Leigh Allen
C. Leigh Allen
AGAndrew M. Gulick
Andrew M. Gulick
Microorganisms produce a variety of natural productsviasecondary metabolic biosynthetic pathways. Two of these types of synthetic systems, the nonribosomal peptide synthetases (NRPSs) and polyketide synthases (PKSs), use large modular enzymes containing multiple catalytic domains in a single protein. These multidomain enzymes use an integrated carrier protein domain to transport the growing, covalently bound natural product to the neighboring catalytic domains for each step in the synthesis. Interestingly, some PKS and NRPS clusters contain free-standing domains that interact intermolecularly with other proteins. Being expressed outside the architecture of a multi-domain protein, these so-called type II proteins present challenges to understand the precise role they play. Additional structures of individual and multi-domain components of the NRPS enzymes will therefore provide a better understanding of the features that govern the domain interactions in these interesting enzyme systems. The high-resolution crystal structure of a free-standing carrier protein fromAcinetobacter baumanniithat belongs to a larger NRPS-containing operon, encoded by the ABBFA_003406–ABBFA_003399 genes ofA. baumanniistrain AB307-0294, that has been implicated inA. baumanniimotility, quorum sensing and biofilm formation, is presented here. Comparison with the closest structural homologs of other carrier proteins identifies the requirements for a conserved glycine residue and additional important sequence and structural requirements within the regions that interact with partner proteins.

Verified
Journal Article
Open access
PDF file
VGVijayalaxmi Gupta
Vijayalaxmi Gupta
SHSheri A. Hild
Sheri A. Hild
SJSudhakar R. Jakkaraj
Sudhakar R. Jakkaraj
ECErick J. Carlson
Erick J. Carlson
HWHenry L. Wong
Henry L. Wong
JTJoseph S Tash
Joseph S Tash
This study shows for the first time that an iminosugar exerts anti-spermiogenic effect, inducing reversible infertility in a species that is not related to C57BL/6 male mice. In CD rats, N-butyldeoxygalactonojirimycin (NB-DGJ) caused reversible infertility at 150 mg/kg/day when administered daily as single oral dose. NB-DGJ inhibited CD rat-derived testicular β-glucosidase 2 (GBA2) activity at 10 µM but did not inhibit CD rat-derived testicular ceramide-specific glucosyltransferase (CGT) at doses up to 1000 µM. Pharmacokinetic studies revealed that sufficient plasma levels of NB-DGJ (50 µM) were achieved to inhibit the enzyme. Fertility was blocked after 35 days of treatment and reversed one week after termination of treatment. The rapid return of fertility indicates that the major effect of NB-DGJ may be epididymal rather than testicular. Collectively, our in vitro and in vivo studies in rats suggest that iminosugars should continue to be pursued as potential lead compounds for development of oral, non-hormonal male contraceptives. The study also adds evidence that GBA2, and not CGT, is the major target for the contraceptive effect of iminosugars.